Incyte: Not Exciting Yet, But Perhaps To Come
AlexanderFord/E+ via Getty Images
Incyte (NASDAQ:INCY) has been a name which I have followed for a while as the company became almost a victim of its own success of the FDA approval for Jakafi back in 2011. This success had a drawback, as the company became…
